Correlation Between Virax Biolabs and Evofem Biosciences
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Evofem Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Evofem Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Evofem Biosciences, you can compare the effects of market volatilities on Virax Biolabs and Evofem Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Evofem Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Evofem Biosciences.
Diversification Opportunities for Virax Biolabs and Evofem Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Virax and Evofem is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Evofem Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evofem Biosciences and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Evofem Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evofem Biosciences has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Evofem Biosciences go up and down completely randomly.
Pair Corralation between Virax Biolabs and Evofem Biosciences
If you would invest (100.00) in Evofem Biosciences on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Evofem Biosciences or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Virax Biolabs Group vs. Evofem Biosciences
Performance |
Timeline |
Virax Biolabs Group |
Evofem Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Virax Biolabs and Evofem Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virax Biolabs and Evofem Biosciences
The main advantage of trading using opposite Virax Biolabs and Evofem Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Evofem Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will offset losses from the drop in Evofem Biosciences' long position.Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Evofem Biosciences vs. National Vision Holdings | Evofem Biosciences vs. Paysafe | Evofem Biosciences vs. Alto Neuroscience, | Evofem Biosciences vs. Schweiter Technologies AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |